Showing 261 - 276 results of 276 for search '"Shenzhen University"', query time: 0.06s Refine Results
  1. 261
  2. 262
  3. 263
  4. 264
  5. 265
  6. 266

    Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 1... by Chen S, Qi H, Tan H, Cao F, Xie L, Huang T, Wu Y, Wen C, Wang Y, Shen L, Fan W

    Published 2025-02-01
    “…Shuanggang Chen,1,2,* Han Qi,1,2,* Hongtong Tan,1,2,* Fei Cao,1,2 Lin Xie,1,2 Tao Huang,1,2 Ying Wu,3 Chunyong Wen,1,2 Yujia Wang,1,2 Lujun Shen,1,2 Weijun Fan1,2 1Department of Minimally Invasive Interventional Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People’s Republic of China; 2State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People’s Republic of China; 3Department of Interventional Therapy, Shenzhen second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518035, People’s Republic of China*These authors contributed equally to this workCorrespondence: Weijun Fan, Email fanwj@sysucc.org.cn; Lujun Shen, Email shenlj@sysucc.org.cnBackground: Salvage liver transplantation is promising for hepatocellular carcinoma(HCC) recurrence post-ablation but is significantly affected by recurrence beyond Milan Criteria (RBM).Materials and Methods: A retrospective cohort study of potentially transplantable HCC patients undergoing ablation between 2007 and 2017 assessed median time to recurrence beyond Milan Criteria(TRBM) via Kaplan-Meier curves and predictive capacity of recurrence and RBM for overall survival(OS) via Receiver Operating Characteristic Curves, and identified independent risk factors for TRBM and RBM via Cox and binary logistic regression models.Results: We enrolled 191 potentially transplantable patients with early-stage HBV-related HCC ≤ 3 cm who underwent ablation. …”
    Get full text
    Article
  7. 267
  8. 268

    iRGD-Targeted Biosynthetic Nanobubbles for Ultrasound Molecular Imaging of Osteosarcoma by Liu T, Liang X, Liu W, Yang S, Cui T, Yan F, Li Z

    Published 2025-01-01
    “…Tingting Liu,1– 3 Xiaoxin Liang,4 Wei Liu,5 Shuai Yang,6 Tao Cui,7 Fei Yan,3 Zhenzhou Li1,2 1Department of Ultrasound, The second People’s Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518061, People’s Republic of China; 2Graduate School, Guangxi University of Chinese Medicine, Nanning, 530200, People’s Republic of China; 3CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, People’s Republic of China; 4Department of Ultrasound, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People’s Republic of China; 5School of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, People’s Republic of China; 6Department of Clinical and Research, Shenzhen Mindray Bio-Medical Electronics Co, Ltd, Shenzhen, 518055, People’s Republic of China; 7Medical Imaging center, Shenzhen Yunshan Yunli Hospital, Shenzhen, 518055, People’s Republic of ChinaCorrespondence: Fei Yan; Zhenzhou Li, Email fei.yan@siat.ac.cn; lizhenzhou2004@126.comPurpose: Osteosarcoma is the most common primary malignant tumor of the bone. …”
    Get full text
    Article
  9. 269
  10. 270
  11. 271
  12. 272
  13. 273
  14. 274
  15. 275
  16. 276